AAP
LXRX icon

Arax Advisory Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History

Arax Advisory Partners’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64 Hold
41
– – ﹤0.01% 3647
2025
Q4 		$47 Sell
41
-5,056
-99% -$6.95K ﹤0.01% 3927
2025
Q3 		$6.88K Buy
+5,097
New +$5.79K ﹤0.01% 2758
2024
Q4 		– Sell
-639
Closed -$1K – 2608
2024
Q3 		$1K Hold
639
– – ﹤0.01% 2257
2024
Q2 		$1.07K Buy
+639
New +$1.15K ﹤0.01% 2153

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.26B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return